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Abstract
Background: Computer Tomography (CT) is considered the gold standard for assessing the morphological
changes of lung parenchyma. Although novel CT techniques have substantially decreased the radiation dose,
radiation exposure is still high. Magnetic Resonance Imaging (MRI) has been established as a radiation- free
alternative to CT for several lung diseases, but its role in infectious diseases still needs to be explored further.
Therefore, the purpose of our study was to compare MRI with high resolution CT (HRCT) for assessing pulmonary
tuberculosis.
Methods: 50 patients with culture-proven pulmonary tuberculosis underwent chest HRCT as the standard of
reference and were evaluated by MRI within 24 h after HRCT. Altogether we performed 60 CT and MRI
examinations, because 10 patients were also examined by CT and MRI at follow- up. Pulmonary abnormalities, their
characteristics, location and distribution were analyzed by two readers who were blinded to the HRCT results.
Results: Artifacts did not interfere with the diagnostic value of MRI. Both HRCT and MRI correctly diagnosed
pulmonary tuberculosis and identified pulmonary abnormalities in all patients. There were no significant differences
between the two techniques in terms of identifying the location and distribution of the lung lesions, though the
higher resolution of MRI did allow for better identification of parenchymal dishomogeneity, caseosis, and pleural or
nodal involvement.
Conclusion: Technical developments and the refinement of pulse sequences have improved the quality and speed
of MRI. Our data indicate that in terms of identifying lung lesions in non-AIDS patients with non- miliary
pulmonary tuberculosis, MRI achieves diagnostic performances comparable to those obtained by HRCT but with
better and more rapid identification of pulmonary tissue abnormalities due to the excellent contrast resolution.
Background
CT is considered the gold standard for assessing the
morphological changes of lung parenchyma. Although
novel CT techniques have substantially decreased the
radiation dose, radiation exposure is still high. Magnetic
Resonance Imaging (MRI) has been established as a
radiation- free alternative to CT for several lung dis-
eases, explaining the growing interest in (MRI) for lung
parenchyma. New technologies and strategies which
allow for very fast imaging and improved image quality
[1,2] have been introduced, but their role in infectious
diseases still needs to be explored further.
MRI of the lung is difficult for several reasons. Major
problems result from susceptibility artifacts caused by
extensive air-tissue parenchymal interfaces and the low-
proton density of normal parenchyma, both of which
are factors that lead to low signal intensity of the nor-
mal lung. Another problem is the continuous motion of
all components induced by heart pulsation and respira-
tion, which are most prominent in the lower and ante-
rior sections of the chest. However, proton density
increases when lung tissue damage determines air space
obliteration, reducing the susceptibility effects. In these
cases, MRI plays a role in assessing lung parenchyma
[1,3-5] and could be useful in diagnosing pneumonia,
due to the exudative accumulation of water and cells
occurring in the air space.
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the lung for various diseases, including pulmonary per-
fusion and ventilation [1,2,5-9], however to our knowl-
edge, no systematic study has been published about
diagnostic MRI in patients with pulmonary tuberculosis.
The aim of our study was to compare HRCT and MRI
lung examinations to identify the features of tuberculo-
sis (TB).
Methods
Patients enrolment and characteristics
Our prospective study received institutional review
board approval (INMI 3/150207) by the local ethical
committee and all patients provided written informed
consent.
The 50 patients (17 women and 33 men, ranging from
21-63 years of age with a median age of 47) who met
our study criteria were referred to undergo HRCT and
MRI imaging. The entry criteria for patients were as fol-
lows: (a) a chest X-ray with pulmonary abnormalities,
(b) culture-proven pulmonary tuberculosis in culture
from sputum (also induced) or bronchoalveolar lavage
(c) absence of contraindication to MR examinations (ex.
cardiac pacemakers, cochlear implants), (d) MRI
obtained within 24 hours of the CT examination, to
avoid divergent results during therapy.
All patients who did not have AIDS or additional con-
comitant infectious diseases were undergoing TB treat-
ment. Altogether we performed 60 CT and MRI
examinations, because 10 patients were also examined
by CT and MRI at follow- up. However we analyzed the
latter examinations to increment the number in our ser-
ies, not to evaluate the effectiveness of therapy
CT
Low dose HRCT was performed on all subjects using a
helical four-channel MDCT scanner (Light Speed QX/i
General Electric Medical System, Milwaukee, Wis).
Unenhanced HRCT was obtained from the apex to the
base of the lung at the end of inspiration, with 1-mm
collimation, a high resolution algorithm, and 10 mm
spacing. A specific mediastinum reconstruction algo-
rithm was employed, and the images were obtained on
lung and mediastinal settings.
To minimize the radiation required for obtaining diag-
nostic scans, the following scanning parameters were
selected: tube current 70 mA, with 100 kV [7].
MRI
Parallel imaging MRI was performed with a 1, 5-T sys-
tem (Signa Excite, General Electric Medical System, Mil-
waukee, Wis, USA), a maximum gradient strength of 33
mT/m, and a slew rate of 120 mT/m/s, using a six-
channel body phased array coil system.
The examinations were performed with expiratory
respiratory and diastolic gating. When pulsation was less
vigorous, pulsation artifacts were reduced [1,6,8]. In
agreement with the literature data [6], we preferred to
use respiratory gating which allowed for continuous
breathing instead of multiple breath hold acquisitions,
also because the shifts of the lung parenchyma relative
to the slice level are reduced. We performed MRI in
expiration because the expiration phase is longer than
the inspiration phase and signal intensity increases with
deflation [8]. Even when MRI was performed in expira-
tory respiration and CT at the end of inspiration, there
was no significant discrepancy between the breathing
positions of the images.
An axial T2-weighted Fast Recovery Fast Spin-Echo
(FR FSE T2) FAT SAT was used with the following
parameters: Echo Time, 90 msec; Repetition Time, 2500
msec; Echo Train Length, 14; bandwidth, 50; slice thick-
ness, 5 mm; slice gap, 2 mm; field of view, 42 cm;
matrix size, 288 × 224, reconstructed to 512.
Fat saturation sequences are very effective because the
attenuated fat signal of the thoracic subcutaneous tissue
reduces the ghosting artifacts of the ventral chest wall
[6] and also increases conspicuity of fluids [9].
This sequence provides good image quality, and with
imaging times of about 120 seconds we obtained enough
slices to assess the entire lung.
The in-room time, including positioning the patient
on the examination table, was approximately 15
minutes.
Imaging Analysis
Both CT and MR images, all made anonymous, were
directly displayed on the monitors of a picture archiving
and communication system (PACS 5.1 Kodak, Roche-
ster, NY, USA) with a window setting appropriate for
lung parenchyma and mediastinum (pixel 2048 × 2560,
display gradation 1021 (10-bit), maximum brightness
750cd/m
2, LCD display device 54 cm). The readers were
asked to assess presence, location and extension of pul-
monary TB.
According to the standardized nomenclature for par-
enchymal findings on CT, consolidation was defined as
a homogenous increase in lung parenchyma attenuation
that obscures the margins of the vessels and airway
w a l l s( a na i rb r o n c h o g r a mm a yb ep r e s e n t ) ;an o d u l e
was defined as a round lesion with a diameter of 3 cm
or smaller; ground glass pattern was defined as a homo-
genous, hazy area of increased attenuation without
obscuration of bronchovascular margins (an air bronch-
ogram may be present); cavitation was defined as a gas-
filled space, contained or not contained within a pul-
monary consolidation, mass, or nodule. Tree in bud
appearance was defined as a linear branching structure
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more, we assessed interstitial changes, in particular mili-
ary, bronchial wall and peribronchial tissue thickening.
Pleural and mediastinal lymph node involvement was
also assessed.
Pleural effusion was defined as free-flowing pleural
fluid producing sickle-shaped opacity (in most cases
posteriorly) and loculated fluid collections as lenticular
opacities in a fixed position. Pleural effusions with a
volume of 15 ml or more can be detected with CT,
however pleuritis sicca is not visible on CT scans.
Lymph nodes were considered enlarged when they were
greater than one centimeter on the short axis. Since
there are no established MRI criteria to define parench-
ymal lung findings, we adopted the CT criteria. Regard-
ing the pleura, MRI can detect subtle signal
abnormalities that might be consistent pleuritis sicca.
Concerning lymph nodes, we also assessed nodal signal
intensity compared with thoracic wall muscle. Previous
reports correlated histological data with MRI features in
tuberculous lymphadenopathy [10], including signal
intensity on unenhanced MR. Based on MRI findings,
lymph node types could be defined according to the
presence and degree of granuloma formation, caseation/
liquefaction necrosis, fibrosis and calcifications. Signal
intensity may differ depending on the stage of evolution:
i) slight hyper-intensity may reflect lymphoid hyperpla-
sia related to inflammation, ii) high hyper-intensity is
suggestive of liquefactive necrosis, and iii) central isoin-
tensity associated with peripheral hyper-intensity may
reflect caseosis.
The MRI findings to be assessed were previously
established by consensus to avoid bias in individual
interpretation.
All MR images were independently analyzed by two
board-certified radiologists (VS, EBR, both with 10 years
of experience in clinical MR imaging and 25 years of
experience in chest imaging). The observers were una-
ware of CT results to avoid interpretation bias. Since
CT is considered the gold standard technique, all CT
images were considered as reference scans and were
analyzed in a randomised order by the same radiologist
in consensus, two months after analyzing the MR
images.
Then, they directly compared MRI with CT examina-
tions in consensus to verify the presence, distribution
and characteristics of pathological features. In divergent
cases, MRI and CT were re-examined to determine
which imaging technique was correct. Disagreements in
image scorings were resolved by consensus. MRI arti-
facts were graded as minimal (barely visible), moderate
(clearly visible, but not interfering with evaluation) and
severe (compromising evaluation). Particular attention
was given to determining whether these artifacts inter-
fered with the diagnostic value.
For CT and MR images, each parenchymal finding
was scored on a scoring sheet using the following sliding
scale of relative certainty: 0 = definitely negative; 1 =
probably negative; 2 = indeterminate; 3 = probably posi-
tive; 4 = definitely positive. To calculate the MRI detec-
tion rate for each finding, we only considered those that
were scored as 0 (definitely negative) and 4 (definitely
positive).
Furthermore, for both imaging techniques, we classi-
fied each lung by zone: upper, middle, and lower, result-
ing in a total of six zones per patient. The upper zones
were defined as areas of the lung above the level of the
carina; the middle zones as areas between the level of
t h ec a r i n aa n dt h eo r i g i no ft h ei n f e r i o rp u l m o n a r y
veins; and the lower zones as areas below the origin of
the inferior pulmonary veins. Each zone had approxi-
mately the same number of sections. We scored lung
zone involvement by using a four-point scale: 0 = no
involvement, 1 = < 25%, 2 = 25%-50%, 3 = > 50%.
Statistical analysis
Statistical analyses were performed using the SPSS/PC+
version 11 (SPSS, Chicago, Ill). A p value lower than
0.05 indicated a statistically significant difference.
The degree of agreement between observers interpret-
ing chest MRI was determined by using pair-wise kappa
statistics as follows: very good, k value > 0.81; good, k
value 0.80-061; moderate, k value 0.60-041. A separate
kappa value was calculated for each sign that was
reviewed.
K statistics were also calculated to analyze the agree-
ment between MRI and CT and a detection rate for
each finding; in this analysis, results were dichotomized
as definitely positive or not.
The chi- square test was used to compare the propor-
tion of images demonstrating different scores of involve-
ment for each zone of the lungs depicted by MRI and
CT.
Results
MR artifacts were negligible in 48 cases (48/60 80%),
and minimal (barely visible) in 12 cases (12/60 20%),
however, these artifacts did not interfere with the diag-
nostic value. There were no motion artifacts or
instances of image distortion due to susceptibility that
resulted in poor image quality.
Pathological findings were observed in all CT and MR
examinations (Table 1) however, in our study we did
not observe miliary or calcified parenchymal lesions.
Concerning MR imaging, agreement between obser-
vers was always very good for each sign (k = 0.98-0.86).
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for consolidations, nodules and cavities. In 4 patients,
MRI easily assessed caseation while CT showed aspecific
hypodensity (Figure 1a, b).
The k value for MRI/CT agreement was 0.90 for
ground glass, 0.86 for tree in bud and 0.78 for interstitial
changes (Figure 2, Figure 3, Figure 4a, b, Figure 5a,b).
Regarding pleural effusion (Figure 6a, b, Figure 7a, b),
the results of the two techniques differed considerably,
and the k value for MRI/CT agreement was 0.54. For
MRI, we found hyper-intensity to be consistent with
pleural involvement in 35% cases (21/60 examinations).
For CT, pleural effusion (free or loculated) was seen in
only 17% (10/60 examinations) of the cases. In the
remaining 11 cases depicted by MRI, 3 cases showed
very subtle pleural effusion (identified on CT by the
reviewers in consensus), and in 8 there was no pleural
abnormality on CT; pleural layers showed a relatively
high signal intensity on T2-weighted images without sig-
nificative thickening or effusion, consistent with inflam-
mation sicca.
Regarding mediastinal lymph nodes (Figure 8a, b), on
MRI we found that in 23% of the cases (14/60 examina-
tions) there was either enlargement and/or signal altera-
tion consistent with nodal involvement; a total of 56
lymph nodes were evaluated. In our series, when com-
pared with the thoracic wall muscle, 89% of the nodes
Table 1 Findings of 60 HRCT examinations and 60 MRI examinations
HRCT score MRI score
01234
Consolidation 52 52
Alteration consistent with caseosis undetermined 4
Cavitation 39 39
Ground glass 6 2 1 4
Nodule 43 43
Tree in bud 33 29
Interstitial changes 14 1 4 13
Lymph nodes (Short axis > 10 mm) 38 56
Edema undetermined 50
Alteration consistent with colliquative necrosis undetermined 2
Alteration consistent with caseosis undetermined 4
Pleural involvement 10 21
0 = definitely negative
1 = probably negative
2 = indeterminate
3 = probably positive
4 = definitely positive
Figure 1 32 year-old man with pulmonary tuberculosis.A )
HRCT shows parenchymal consolidation with cavitations. B)
Unenhanced MRI better depicts caseosis, air level in the cavities and
pleural effusion.
Figure 2 28 year-old man with pulmonary tuberculosis, HRCT
shows bronchogenic spread and interstitial changes with
peribronchial thickening.
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phoid hyperplasia), 7% showed central isointensity asso-
ciated with peripheral hyperintensity (most likely
reflecting caseosis), and 3.5% were highly hyper-intense,
suggesting liquefactive necrosis.
A total of 38 lymph nodes were evaluated on unen-
hanced CT. Nodal involvement, assessable only as an
enlargement, was seen in 16% of the cases (10/60 exami-
nations). In the remaining 4 patients, nodal involvement
(depicted by MRI as hyperintensity) was not identified
on CT by the reviewers in consensus, nor at re-exami-
nation, because the nodal short axis remained < 10 mm.
We examined the lymph nodes (which were identified
as pathological on HRCT and MRI because the short
axis was greater than 10 mm) to choose which imaging
technique enabled correct diagnosis of nodal involve-
ment. We observed that MRI depicted signal alterations
in all of the lymph nodes that were enlarged on CT.
The same MR signal alterations were observed in lymph
nodes that were not enlarged on CT. These data suggest
that MRI have a higher sensitivity for detecting nodal
involvement. In all patients, both MR and CT examina-
tions showed identical results concerning the location of
parenchymal features (Table 2).
Discussion
Today CT represents the gold standard for assessing
lung parenchyma. MRI has some relevant clinical appli-
cation, but it is not used in routine clinical management.
Several recent studies clearly demonstrated that MRI
Figure 3 Same patient reported in Fig.2: 28 year-old man with
pulmonary tuberculosis, unenhanced MRI identifies the same
features as well as HRCT in figure 2.
Figure 4 44 year-old man with pulmonary tuberculosis.A )
HRCT shows interstitial changes with peribronchial thickening. B)
Unenhanced MRI identifies the same features as well as HRCT.
Figure 5 53 year-old woman with pulmonary tuberculosis.A )
HRCT shows interstitial changes with peribronchiolar thickening. B)
Unenhanced MRI identifies the same features as well as HRCT and
also depicts lymph node caseosis.
Figure 6 38 year-old man with pulmonary tuberculosis.A )
HRCT shows parenchymal consolidation. B) Unenhanced MRI
depicts colliquative necrosis within consolidation, subtle, free and
loculated pleural effusion, and a highly hyper-intense mediastinal
lymph node.
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cant diagnostic advantages over CT in terms of higher
contrast resolution and absence of exposure to radiation.
However, CT is cheaper, more widespread, rapid to per-
form, and has an established role in clinical manage-
ment. On the other hand, the disadvantages of MRI,
such as limited spatial resolution and motion and sus-
ceptibility artifacts, have been overcome by using new
techniques. In agreement with literature, our study indi-
cates that regarding presence and distribution of patho-
logical lung features, MRI and CT show the same
results, even regarding lung tuberculosis.
Based on a one- to -one correlation between MRI and
CT, the findings in both techniques regarding consolida-
tions, nodules and cavities correlated well, and indeed
obtained the same results when identifying these
characteristics.
On the contrary, although MRI identified parenchymal
changes, on 4 occasions it failed to diagnose “tree in
bud”, probably misinterpreted as interstitial changes.
These false negative results for bronchogenic spread
were made because of the lower MR spatial resolution.
Likewise, the missed identification of interstitial changes,
verified in one follow- up case, was due to very subtle
involvement and lower MR spatial resolution.
Moreover small areas of “ground glass” were missed 3
times, misinterpreted as blurring.
It might be useful to consider performing MRI at the
end of inspiration, or using a FR FSE T2 without fat sat
to visualize the parenchyma [7,11,12] in order to reduce
these limiting factors.
However, because of the excellent contrast resolution,
MR examinations show immediate results and are even
more accurate in revealing lymph node involvement,
pleural abnormalities and parenchymal caseation than
unenhanced CT.
Indeed, MRI indicated nodal involvement in 14
patients and parenchymal caseation in 4 of these, fea-
tures not clearly identified by the CT. However, the CT
examination was unenhanced, thus could not allow for
correct diagnosis. To our knowledge, no investigators
have focused on the MRI features of thoracic tubercu-
lous lympadenopathies. In our series, 89% were slight
hyper-intense, 7% were isointense with peripheral hyper-
intensity, and 3.5% were highly hyper-intense compared
with the thoracic wall muscle. Signal intensity may differ
depending on the stage of evolution, where slight hyper-
intensity may indicate lymphoid hyperplasia related to
inflammation, high hyper-intensity is suggestive of lique-
factive necrosis, and central isointensity associated with
peripheral hyper-intensity may indicate caseosis. All
these findings are in line with previous reports regarding
Figure 7 61 year-old woman with pulmonary tuberculosis.A )
HRCT shows cavited infiltrate. B) Unenhanced MRI identifies the
same features as well as HRCT and identifies subtle, free pleural
effusion, and a highly hyper-intense mediastinal lymph node.
Figure 8 53 year-old woman with pulmonary tuberculosis.A )
HRCT, reconstructed for mediastinum, shows an enlarged
pretracheal lymph node, B) Unenhanced MRI also depicts lymph
node caseosis.
Table 2 Detection and percentage of pulmonary
involvement in 60 HRTC and 60 MRI images
Location Score 0 Score 1 Score 2 Score 3 P value
CT MRI CT MRI CT MRI CT MRI
Right lung
Upper zone 224 224 33 33 3 3 32 24 0.79 (ns)
Middle zone 48 48 33 24 40 24 16 16 0.40 (ns)
Lower zone 265 249 40 57 8 9 9 10 0.31 (ns)
Left lung
Upper zone 116 116 40 40 48 48 182 182 1 (ns)
Middle zone 24 24 24 24 32 24 74 83 0.64 (ns)
Lower zone 99 88 107 116 40 32 16 25 0.27 (ns)
0 = no involvement
1 = < 25%,
2 = 25%-50%,
3 = > 50%.
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histological data with MRI features [13].
Because of its excellent contrast resolution, MRI is
superior to CT in assessing pleural involvement [14].
Indeed, MRI promptly depicted pleural abnormalities with
a higher percentage than CT (35% vs. 17%) with the same
immediateness for subtle or loculated effusions (not seen
on CT) and pleural hyper-intensity, consistent with early
sicca inflammation, which was never observed on CT.
From our experience, MR was not only useful for inte-
grating diagnostic evaluation of the lung, but the results
of our study even suggest that MRI could replace CT in
assessing lung tuberculosis in some subsets of patients
such as children, women, during pregnancy (MR ima-
ging should be avoided during the first trimester), follow
-ups, or as an alternative to CT for patients with aller-
gies to IV contrast material. Performing MRI in children
with TB may also prove to be interesting since they may
have lymph node involvement rather than lung involve-
ment; however it should be taken into account that
anaesthesia may be required.
Conclusion
We believe that MRI is comparable to CT for identify-
ing morphological pulmonary changes, and that MRI is
clearly superior to CT regarding tissue characterization.
Furthermore, on the basis of lesion signal intensity, MRI
could differentiate the exudative stage of lung TB from
the relatively acellular fibrotic phase because of the rela-
tively “short T2” in fibrotic tissues [15].
The shortcomings of our study are the limited number
of patients and the absence of miliary and calcified
nodules found in the enrolled patients, thus it could not
be proved that these lesions can be identified by MRI.
The lack of histopathological correlation or microbiolo-
gical tests of the adenopathies is another important lim-
itation of the study, and MRI in the phase of expiration
may show non-pathological processes such as small
laminar atelectasis. Moreover, further studies are needed
to determine whether the use of FR FSE T2 sequences
without fat sat might improve visualization of the
parenchyma.
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